Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Russell Clayton Insider Profile
4 Followers
Russell Clayton, Senior VP, R&D at Windtree Therapeutics, holds 22.50K shares in Larimar Therapeutics (Ticker: LRMR), holds 31.55K shares in Windtree Therapeutics (Ticker: WINT).
Russell Clayton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Russell Clayton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Russell Clayton
Russell Clayton's Trading History
Windtree Therapeutics
May 08, 2012
Senior VP, R&D
Uninformative Buy
4.25K
$16.09K
Larimar Therapeutics
Jan 19, 2024
CMO
Uninformative Buy
―
$136.80K
List of latest transactions for each holding click on a transaction to see Russell Clayton's performance on stock
You May Also Like
Russell Clayton insider profile FAQ
What is the percentage of profitable transactions made by Russell Clayton?
The percentage of profitable transactions made by Russell Clayton is ―.
What is the average return per transaction made by Russell Clayton?
The average return per transaction made by Russell Clayton is ―.
What stocks does Russell Clayton hold?
Russell Clayton holds: WINT, LRMR stocks.
What was Russell Clayton’s latest transaction?
Russell Clayton latest transaction was an Uninformative Buy of ―.
What was Russell Clayton's most profitable transaction?
Russell Clayton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Russell Clayton's role in Windtree Therapeutics?
Russell Clayton's role in Windtree Therapeutics is Senior VP, R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.